Trial Profile
Comparative study of glimepiride and nateglinide on glycemic control in patients with type 2 diabetes mellitus treated with voglibose
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2012
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Nateglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Feb 2009 New trial record.